These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 557411)

  • 1. Supersensitivity to apomorphine following destruction of the ascending dopamine neurons: quantification using the rotational model.
    Marshall JF; Ungerstedt U
    Eur J Pharmacol; 1977 Feb; 41(4):361-7. PubMed ID: 557411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Striatal cell supersensitivity to apomorphine in dopamine-lesioned rats correlated to behaviour.
    Schultz W; Ungerstedt U
    Neuropharmacology; 1978 Jun; 17(6):349-53. PubMed ID: 566861
    [No Abstract]   [Full Text] [Related]  

  • 3. Behavioral quantification of striatal dopaminergic supersensitivity after bilateral 6-hydroxydopamine lesions in the mouse.
    Mandel RJ; Wilcox RE; Randall PK
    Pharmacol Biochem Behav; 1992 Feb; 41(2):343-7. PubMed ID: 1574523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 6-hydroxydopamine rotational model for the detection of dopamine agonist activity: reliability of effect from different locations of 6-hydroxydopamine.
    Costall B; Naylor RJ; Pycock C
    J Pharm Pharmacol; 1975 Dec; 27(12):943-6. PubMed ID: 2668
    [No Abstract]   [Full Text] [Related]  

  • 5. Rotational behaviour in rats with unilateral striatal kainic acid lesions: a behavioural model for studies on intact dopamine receptors.
    Schwarcz R; Fuxe K; Agnati LF; Hökfelt T; Coyle JT
    Brain Res; 1979 Jul; 170(3):485-95. PubMed ID: 37986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
    Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE
    Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings: Dopamine neurones and electrical self-stimulation in the lateral hypothalamus.
    Christie JE; Ljungberg T; Ungerstedt U
    J Physiol; 1973 Oct; 234(2):80P-81P. PubMed ID: 4797454
    [No Abstract]   [Full Text] [Related]  

  • 9. Behavioral correlates of dopaminergic supersensitivity.
    Iversen SD; Creese I
    Adv Neurol; 1975; 9():81-92. PubMed ID: 1170717
    [No Abstract]   [Full Text] [Related]  

  • 10. Selective 6OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats.
    Kelly PH; Iversen SD
    Eur J Pharmacol; 1976 Nov; 40(1):45-56. PubMed ID: 1033072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supersensitivity to dopamine agonists following unilateral, 6-hydroxydopamine-induced striatal lesions in mice.
    Thornburg JE; Moore KE
    J Pharmacol Exp Ther; 1975 Jan; 192(1):42-9. PubMed ID: 1168250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supersensitivity of the cholinergic response to apomorphine in the striatum following denervation or disuse supersensitivity of dopaminergic receptors in the rat.
    Consolo S; Ladinsky H; Samanin R; Bianchi S; Ghezzi D
    Brain Res; 1978 Oct; 155(1):45-54. PubMed ID: 210895
    [No Abstract]   [Full Text] [Related]  

  • 13. Non-specific supersensitivity of striatal dopamine receptors after 6-hydroxydopamine lesion of the nigrostriatal pathway.
    Costall B; Naylor RJ; Pycock C
    Eur J Pharmacol; 1976 Feb; 35(2):276-83. PubMed ID: 942921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-Hydroxydopamine lesions of olfactory tubercles and caudate nuclei: effect on amphetamine-induced stereotyped behavior in rats.
    Asher IM; Aghajanian GK
    Brain Res; 1974 Dec; 82(1):1-12. PubMed ID: 4373138
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of B-HT 920 on nigrostriatal and mesolimbic dopamine systems in normosensitive and supersensitive rats.
    Clarke PB; Wyder KJ; Jakubovic A; Fibiger HC
    Br J Pharmacol; 1990 Mar; 99(3):509-15. PubMed ID: 2110017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
    Costall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circling behavior in normoxic or hypoxic rats with unilateral 6-OHDA nigrostriatal lesion. Part 1. Effects of apomorphine and L-dopa.
    Saligaut C; Daoust M; Moore N; Boismare F
    Methods Find Exp Clin Pharmacol; 1987 Apr; 9(4):219-24. PubMed ID: 3110513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasticity of [14C]2-deoxy-D-glucose incorporation into neostriatum and related structures in response to dopamine neuron damage and apomorphine replacement.
    Kozlowski MR; Marshall JF
    Brain Res; 1980 Sep; 197(1):167-83. PubMed ID: 7397550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioural supersensitivity to apomorphine following cerebral dopaminergic denervation by 6-hydroxydopamine.
    Nahorski SR
    Psychopharmacologia; 1975 May; 42(2):159-62. PubMed ID: 1172249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced rotational behaviour following unilateral intracerebral injection of saline-ascorbate solution: neurotoxicity of ascorbic acid and monoamine-independent circling.
    Waddington JL; Crow TJ
    Brain Res; 1979 Feb; 161(2):371-6. PubMed ID: 310332
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.